Please contact our sales representative to learn more information about this reagents.
Background
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer. This drug was developed by AltaRex Corp.